Previous Article | Next Article ![]()
Journal of Clinical Microbiology, March 2001, p. 1124-1129, Vol. 39, No. 3
Istituto di Malattie Infettive e Tropicali,
Università di Milano, Ospedale Luigi Sacco, Milan, Italy
Received 21 April 2000/Returned for modification 24 August
2000/Accepted 15 December 2000
We studied the human immunodeficiency virus type 1 phenotypic and
genotypic profiles of a dual drug-resistant isolate (isolate 14aPost-DR) selected for zidovudine (ZDV) and lamivudine (3TC) resistance and then cultured in the presence of 3TC and a protease inhibitor: indinavir (IDV), ritonavir, or KNI-272. The IDV-treated virus was highly resistant to 3TC, ZDV, and IDV and accumulated protease mutations at positions M46I and V82F. A change from alanine to
valine was observed in 4 of 10 clones in the P2 position of the p7-p1
Gag-protease cleavage site, linked to position M46I in the dominant
viral quasispecies. Previous 3TC resistance did not impair the
development of additional mutations in the protease and Gag-protease
cleavage regions.
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.3.1124-1129.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
In Vitro Evolution of the Human Immunodeficiency
Virus Type 1 Gag-Protease Region and Maintenance of Reverse
Transcriptase Resistance following Prolonged Drug Exposure


*
Corresponding author. Mailing address: Istituto di
Malattie Infettive e Tropicali, Università di Milano, Ospedale
Luigi Sacco, via GB Grassi 74, 20157 Milan, Italy. Phone:
011.39.02.39043350. Fax: 011.39.02.3560805. E-mail:
rusconi{at}mailserver.unimi.it.
This report is dedicated to the memory of Alessandro Caporali.
Present address: Infectious Disease Unit, Massachusetts General
Hospital-East, Charlestown, MA 02129.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»